US 10,376,537 B2
Antiviral composition and method of use
Andreas Grassauer, Vienna (AT); Eva Prieschl-Grassauer, Vienna (AT); Christiane Koller, Seyring (AT); and Alexander Pretsch, Roseldorf (AT)
Assigned to MARINOMED BIOTECH AG, Vienna (AT)
Filed by Andreas Grassauer, Vienna (AT); Eva Prieschl-Grassauer, Vienna (AT); Christiane Koller, Seyring (AT); and Alexander Pretsch, Roseldorf (AT)
Filed on Aug. 23, 2012, as Appl. No. 13/592,624.
Application 13/592,624 is a division of application No. 12/312,926, granted, now 8,282,969, previously published as PCT/EP2007/010512, filed on Dec. 4, 2007.
Application 12/312,926 is a continuation in part of application No. 11/567,078, filed on Dec. 5, 2006, abandoned.
Claims priority of application No. 06450176 (EP), filed on Dec. 5, 2006.
Prior Publication US 2012/0315311 A1, Dec. 13, 2012
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 36/02 (2006.01); A61K 31/731 (2006.01)
CPC A61K 31/731 (2013.01) 20 Claims
 
1. A method of reducing the risk of acquiring a rhinovirus infection in a subject in need thereof, the method comprising administering to the subject a pharmaceutical composition comprising, as the sole active antiviral ingredient, an iota-carrageenan homopolymer and/or heteropolymer in an antiviral effective amount,
wherein the administration is carried out topically by application to either of, or to both of, the skin and nasal mucosa, and
wherein the composition further comprises at least one non-carrageenan pharmaceutically active compound selected from the group consisting of a steroid and an antihistamine.